Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check2 days agoChange DetectedThe page now indicates that recruitment for this study is closed, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting adjustment to the Intervention/Treatment header and a version update from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This is a metadata change that does not modify the study content or visible information.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new Revision label (v3.5.4) replacing the previous version, indicating a backend/UI maintenance update rather than an addition or deletion of study content.SummaryDifference0.0%

- Check38 days agoChange DetectedRheumatoid arthritis is now listed as a study topic, and related topics including MedlinePlus Genetics are added, expanding the page's navigational context and external resource connections.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s location entries were adjusted to reflect more precise geographic labels (e.g., “State of Vienna” and “Adazi, Latvia”) while removing older variants. The page version/revision indicator was also updated.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.